Friday 6 November 2026 Export AXSM’s income statement to Excel — free account

Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $638.5 million, up 65.5% from fiscal 2024.

Revenue: +51.9%
EPS: +73.9%
Free cash flow: −1,078.3%
Total debt: +4.04%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

132.13 2.33 +1.80%

Follow AXSM

Alert me

Market cap: $6.8B
P/E: 0.0×
Fwd P/E: −49.2×
Dividend yield: —
F-score: 5/9
Altman Z: 6.91
Beneish M: −2.53
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	5	5	5	5
ROE Full definition →		(252.11%)	(349.38%)	(245.10%)	(175.59%)
ROA Full definition →		(29.11%)	(28.74%)	(27.35%)	(21.03%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(86.93%)	(109.12%)	(97.28%)	(72.87%)
Average Days of Receivables Full definition →		128.32	129.39	130.41	144.74
Free Cash Flow per Share Full definition →		(1.89)	(1.39)	(1.39)	(1.58)
Free Cash Flow Full definition →		(93.88)	(70.99)	(71.96)	(82.61)
Capital Expenditures Full definition →		(0.48)	(0.26)	(0.70)	(0.84)
Other line items
Cash ROIC Full definition →		(17.61%)	(14.69%)	(13.57%)	(15.12%)
Accounts Receivable Turnover Full definition →		3.48	3.43	3.26	3.21
Accounts Payable Turnover Full definition →		0.69	0.55	0.62	0.78
Inventory Turnover Full definition →		2.17	2.19	1.87	1.76
Average Days of Payables Full definition →		503.83	743.05	548.71	600.24
Days of Inventory on Hand Full definition →		214.78	219.46	263.23	266.02
Tax Rate Full definition →		(0.01)	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		28.70%	26.99%	24.19%	22.92%
Selling, General and Administrative Expense of Revenue Full definition →		89.37%	89.63%	91.77%	88.47%
Share Based Compensation of Revenue Full definition →		14.68%	13.26%	12.42%	11.52%
Interest Coverage Full definition →		(25.43)	(32.60)	(37.09)	(26.88)
Operating CF/Net income Full definition →		0.51	0.38	0.37	0.52
Depreciation/Fixed assets Full definition →		18.45	17.80	12.11	11.92
Capex/Depreciation Full definition →		(0.05)	(0.03)	(0.07)	(0.07)
Revenue per Share Full definition →		12.83	13.83	14.99	16.50
Operating CF per Share Full definition →		(1.88)	(1.38)	(1.38)	(1.56)
Capex per Share Full definition →		(0.01)	(0.01)	(0.01)	(0.02)
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly